These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4061754)

  • 21. [Colony growth by various malignant cells of cancer patients on in vitro colony assay].
    Inoue K; Arakawa M; Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ikeda K; Usui N; Nakada H; Adachi K
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1456-63. PubMed ID: 6520505
    [No Abstract]   [Full Text] [Related]  

  • 22. [Significance of the colony formation test in ovarian carcinoma].
    Runge HM; Bücke W; Neumann HA
    Onkologie; 1984 May; 7 Suppl 2():66-73. PubMed ID: 6235468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on in vitro testing on new drugs in ovarian cancer and melanoma.
    Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
    Cancer Treat Rep; 1981; 65(5-6):532-3. PubMed ID: 7195308
    [No Abstract]   [Full Text] [Related]  

  • 24. The human tumour colony-forming assay using fresh specimens.
    Slee PH; Van Oosterom AT; Van den Berg L; De Bruijn EA
    Neth J Med; 1986; 29(6):180-8. PubMed ID: 3016578
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of the human tumor stem cell assay to study chemotherapy sensitivity in cancer of the cervix.
    Parker RL; Welander CE; Homesley HD; Jobson VW; Kawamoto EH
    Obstet Gynecol; 1984 Sep; 64(3):412-6. PubMed ID: 6462571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The response of cells to anti-tumour drugs estimated by limiting dilution in microwell culture].
    Wan JH; Morley AA
    Yao Xue Xue Bao; 1985 Jun; 20(6):418-22. PubMed ID: 3868292
    [No Abstract]   [Full Text] [Related]  

  • 27. Human tumor stem-cell clonogenic assay--another failed cancer fad?
    Hall TC
    Hawaii Med J; 1984 Oct; 43(10):374-8. PubMed ID: 6511386
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clonogenic tests (stem cell assays): therapeutic problems and perspectives in ovarian cancer].
    Aapro MS
    Gynakol Rundsch; 1983; 23 Suppl 4():15-9. PubMed ID: 6674021
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
    Song Y; Shen K; Tang PP
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study on the sensitivities of seven human cancer cell lines to rubescensine A].
    Li XT; Lin C; Li PY; Zhang TM
    Yao Xue Xue Bao; 1985 Apr; 20(4):243-6. PubMed ID: 4072693
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cytostatic-sensitive and cytostatic-resistant leukemias].
    Vilpo JA
    Duodecim; 1989; 105(11):1117-22. PubMed ID: 2666094
    [No Abstract]   [Full Text] [Related]  

  • 32. Time- and dose-dependence of DNA fragmentation induced by anticancer agents: a flow cytometric study.
    Cappella P; Onado C; Sena G; Montalenti F; Spinelli L; Ubezio P
    Eur J Histochem; 1997; 41 Suppl 2():67-8. PubMed ID: 9859787
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anticancer drug sensitivity tested by tumor stem cell assay].
    Hiraki S; Ohnoshi T; Miyai M; Numata T; Kishimoto N; Miyamoto H; Kimura I
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1139-45. PubMed ID: 6471420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of colony-forming cell assays in the evaluation of ovarian cancer.
    Aapro MS; Vermorken JB
    Eur J Cancer Clin Oncol; 1988 Mar; 24(3):357-8. PubMed ID: 3383939
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of amifostine on the in vitro cytotoxicity of chemotherapeutic agents in three epithelial ovarian carcinoma cell lines.
    Ng TY; Ngan HY; Cheng DK; Wong LC
    Gynecol Oncol; 1999 Nov; 75(2):194-7. PubMed ID: 10525371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human tumor cloning assay: clinical applications for ovarian, gastric, pancreatic, and colorectal cancers.
    Weiss G; Von Hoff DD
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):69-74. PubMed ID: 3840279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Culture and sensitivity testing of tumors.
    Von Hoff DD; Forseth B; Gonzales L
    Tex Med; 1986 Sep; 82(9):32-5. PubMed ID: 3775684
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma.
    Gronlund B; Hansen HH; Høgdall C; Engelholm SA
    Cancer; 2002 Oct; 95(8):1656-62. PubMed ID: 12365013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.